Association of Emergency Department Opioid Administration With Ongoing Opioid Use: A Retrospective Cohort Study of Patients With Back Pain. (30th July 2020)

• Record Type: Journal Article
• Authors: Heard, Kennon; Ledbetter, Caroline M.; Hoppe, Jason A.
• Editors: Mycyk, Mark B.
• Is Part Of: Academic emergency medicine. Volume 27:Number 11(2020)
• Page Start: 1158
• Page End: 1165
• Publication Date: 2020-07-30
• Subjects: Emergency medicine -- Periodicals; 616.02505
• DOI: 10.1111/acem.14071
• Languages: English
• ISSNs: 1069-6563

Abstract

Abstract: Objectives: Opioids are commonly administered in the emergency department (ED) and prescribed for the treatment of back pain. It is important to understand the unintended consequences of this approach to inform treatment decisions and the consideration of alternative treatments. Recent evidence has shown that ED opioid prescriptions are associated with future opioid use. The objective of this study was to measure the association of opioid administration in the ED to patients treated for back pain with future opioid use. Methods: This is a retrospective study of opioid‐naïve adults discharged from the ED with a diagnosis of back pain. Patients were stratified by opioid therapy (none, ED administration only, prescription only, or ED administration + prescription). Relative risks of ongoing opioid use (filling >90‐day supply in 180 days following ED visit as documented in the prescription drug monitoring program) were calculated for each opioid‐therapy group and compared to the no‐opioid group. Results: We identified 24, 487 opioid naïve back pain patients. The median age was 38 years, 55% were female, and 56% were non‐Hispanic white. A total of 41% received no opioid, 10% were only administered an opioid in the ED, 18% only received a prescription, and 31% received an opioid in the ED + prescription. The adjusted relative risks of ongoing use compared to the no opioid group were as follows: ED only 1.9, prescription only 2.1, and ED + prescription 2.3. The increased risk persisted for other definitions of ongoing use and after adjustment for baseline pain scores. Conclusions: For opioid‐naïve patients with back pain, both administration of an opioid in the ED and opioid prescriptions are associated with a doubling of the risk of ongoing opioid use compared to patients not treated with opioids. This supports the consideration of minimizing exposure to opioids while treating back pain in the ED.